Journal article

A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma

Greg Hapgood, Janey M Stone, Diana Zannino, Anup George, Paula Marlton, Henry Miles Prince, Chi-Hung Hui, Ian Prosser, Ian D Lewis, Kenneth Bradstock, John F Seymour

Leukemia & Lymphoma | TAYLOR & FRANCIS LTD | Published : 2019